Effects of Huperzine A in Treatment of Moderate to Severe TBI

NCT01676311 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Insufficient accrual rate: 14 participants enrolled (target of 30).

Conditions

Traumatic Brain Injury

Interventions

DRUG: Huperzine A
DRUG: Placebo

Sponsor

Spaulding Rehabilitation Hospital